Biblio Discovery — Demo Discovery Service

4 hasil untuk "Richard Appleton"

Menampilkan 1–4 · 1,94 detik · RSS

  1. Artikel Jurnal

    Resource implications of preparing individual participant data from a clinical trial to share with external researchers

    Catrin Tudur Smith; Sarah Nevitt; Duncan Appelbe dkk.

    Trials, Vol. 18 No. 1 · 2017 · Inggris · DOAJ Scopus

    Abstract Background Demands are increasingly being made for clinical trialists to actively share individual participant data (IPD) collected from clinical trials using responsible methods that protect the confidentiality and privacy of clinical trial participants. Clinical trialists, particularly…

  2. Artikel Jurnal

    Enhancing practitioners’ confidence in recruitment and consent in the EcLiPSE trial: a mixed-method evaluation of site training – a Paediatric Emergency Research in the United Kingdom and Ireland (PERUKI) study

    Kerry Woolfall; Louise Roper; Amy Humphreys dkk.

    Trials, Vol. 20 No. 1 · 2019 · Inggris · DOAJ Scopus

    Abstract Background EcLiPSE (Emergency treatment with Levetiracetam or Phenytoin in Status Epilepticus in children) is a randomised controlled trial (RCT) in the United Kingdom. Challenges to success include the need to immediately administer an intervention without informed consent and changes in…

  3. Artikel Jurnal

    Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II)

    Girvan Burnside; Munir Pirmohamed; Dyfrig A Hughes dkk.

    BMJ Open, Vol. 10 No. 8 · 2020 · Inggris · DOAJ Scopus

    Introduction Antiepileptic drugs (AEDs) are the mainstay of epilepsy treatment. Over the past 20 years, a number of new drugs have been approved for National Health Service (NHS) use on the basis of information from short-term trials that demonstrate efficacy. These trials do not provide…

  4. Artikel Jurnal

    Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs

    Anthony G Marson; Girvan Burnside; Richard Appleton dkk.

    Health Technology Assessment, Vol. 25 No. 75 · 2021 · Inggris · DOAJ Scopus

    Background: Levetiracetam (Keppra®, UCB Pharma Ltd, Slough, UK) and zonisamide (Zonegran®, Eisai Co. Ltd, Tokyo, Japan) are licensed as monotherapy for focal epilepsy, and levetiracetam is increasingly used as a first-line treatment for generalised epilepsy, particularly for women of childbearing…